Friday, May 22, 2015 | Latest E-book
You are here:
Sun Pharma
#

Sun Pharma

Articles

View all

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Apr 28, 2015

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said. #Sun Pharma #Ranbaxy #Dilip Shanghvi #drugmaker
Daiichi Sankyo's misery ends, block deal to give company coup de grce

Apr 22, 2015

Daiichi Sankyo's misery ends, block deal to give company coup de grce

Even after allowing for control premium, the price that Daiichi Sankyo paid for Ranbaxy Laboratories was clearly excessive, and those in the know said sagely that winners curse would have its say sooner than later. #Ranbaxy Laboratories #Sun Pharma #CompanyWatch #Daiichi Sankyo #Diageo #USFDA #United Spirits #Dilip Sanghvi
Daiichi Sankyo to exit Sun Pharma, sell its 9% stake for up to Rs 22,000 cr

Apr 21, 2015

Daiichi Sankyo to exit Sun Pharma, sell its 9% stake for up to Rs 22,000 cr

The shares are being sold in the indicative price band of between 930 rupees and 1,043.80 rupees apiece #Sun Pharma #Ranbaxy #Daiichi Sankyo #Dilip Shanghvi
Exit strategy: Daiichi Sankyo to sell entire stake in Sun Pharma worth Rs 22,000 cr

Apr 21, 2015

Exit strategy: Daiichi Sankyo to sell entire stake in Sun Pharma worth Rs 22,000 cr

Daiichi is planning to sell the nearly 9% stake it currently holds in Indian pharma major Sun Pharmaceuticals, worth about Rs 22,300 crore at Monday's close of market, through block deals on Tuesday. #Sun Pharma #Ranbaxy #Daiichi Sankyo #Shasun Pharmaceuticals

BLOG POSTS

View all

Flop show? Indian pharma rolls back its drug discovery ambitions

May 09, 2011

Flop show? Indian pharma rolls back its drug discovery ambitions

Indian pharmaceutical companies have tried to speed up drug discoveries by hiving research off into separate companies. But as the Piramal decision shows, they are re-merging these companies. Has the strategy failed? #Piramal Healthcare #Dr Reddy's #Sun Pharma #Drug research #NCEs #CorporateStrategy